| Haber: |
Haber Kaynağı: Çeşitli Haber Siteleri
STAT+: Pharmalittle: CVS whistleblower suit details plans to boost consumer drug costs; Roche reports negative Alzheimer’s trial results
Starting in 2015, a whistleblower lawsuit alleges CVS Health coordinated an effort to prevent consumers from obtaining low-cost generics.
https://www.statnews.com/pharmalot/2022/06/16/covid19-vaccine-moderna-patent-wto-monkeypox-cvs-medicare-roche-alzheimers-oxycontin/?utm_campaign=rss
|
